256 related articles for article (PubMed ID: 33277285)
1. Randomised controlled trial of conditioning regimen for cord blood transplantation for adult myeloid malignancies comparing high-dose cytarabine/cyclophosphamide/total body irradiation with versus without G-CSF priming: G-CONCORD study protocol.
Terakura S; Konuma T; Tanaka M; Ozawa Y; Onizuka M; Nanno S; Onishi Y; Aotsuka N; Kondo T; Kawakita T; Kato J; Kobayashi T; Nishida T; Yamaguchi T; Kuwatsuka Y; Takahashi S
BMJ Open; 2020 Dec; 10(12):e040467. PubMed ID: 33277285
[TBL] [Abstract][Full Text] [Related]
2. Significance of Granulocyte Colony-Stimulating Factor-Combined High-Dose Cytarabine, Cyclophosphamide, and Total Body Irradiation in Allogeneic Hematopoietic Cell Transplantation for Myeloid Malignant Neoplasms.
Nakamura Y; Tanaka Y; Tanaka M; Yamamoto K; Matsuguma M; Kajimura Y; Tokunaga Y; Yujiri T; Tanizawa Y
Transplant Proc; 2019 Apr; 51(3):896-900. PubMed ID: 30979482
[TBL] [Abstract][Full Text] [Related]
3. Effect of Granulocyte Colony-Stimulating Factor-Combined Conditioning in Cord Blood Transplantation for Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia: A Retrospective Study in Japan.
Konuma T; Takahashi S; Uchida N; Kuwatsuka Y; Yamasaki S; Aoki J; Onishi Y; Aotsuka N; Ohashi K; Mori T; Masuko M; Nakamae H; Miyamura K; Kato K; Atsuta Y; Kato S; Asano S; Takami A; Miyazaki Y;
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1632-40. PubMed ID: 25985920
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes following the addition of granulocyte colony-stimulating factor-combined high-dose cytarabine to total body irradiation and cyclophosphamide conditioning in single-unit cord blood transplantation for myeloid malignancies.
Konuma T; Ooi J; Nagayama H; Tomonari A; Tsukada N; Kato S; Kawakita T; Isobe M; Monna-Oiwa M; Tojo A; Iseki T; Takahashi S
Ann Hematol; 2022 Jan; 101(1):177-189. PubMed ID: 34591162
[TBL] [Abstract][Full Text] [Related]
5. The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial.
Xuan L; Dai M; Jiang E; Wang Y; Huang F; Fan Z; Xu N; Nie D; Liang X; Chen H; Ye J; Shi P; Liu H; Jin H; Lin R; Yan C; Zhang Y; Sun J; Han M; Liu Q
Lancet Haematol; 2023 Mar; 10(3):e178-e190. PubMed ID: 36702138
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of high-dose cytarabine added to CY/TBI in cord blood transplantation for myeloid malignancy.
Arai Y; Takeda J; Aoki K; Kondo T; Takahashi S; Onishi Y; Ozawa Y; Aotsuka N; Kouzai Y; Nakamae H; Ota S; Nakaseko C; Yamaguchi H; Kato K; Atsuta Y; Takami A;
Blood; 2015 Jul; 126(3):415-22. PubMed ID: 26031916
[TBL] [Abstract][Full Text] [Related]
7. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
[TBL] [Abstract][Full Text] [Related]
8. Favorable Outcome with Conditioning Regimen of Flu/Bu4/Mel in Acute Myeloid Leukemia Patients in Remission Undergoing Cord Blood Transplantation.
Mizuno S; Takami A; Kawamura K; Shimomura Y; Arai Y; Konuma T; Ozawa Y; Sawa M; Ota S; Takahashi S; Anzai N; Hiramoto N; Onizuka M; Nakamae H; Tanaka M; Murata M; Kimura T; Kanda J; Fukuda T; Atsuta Y; Yanada M
Transplant Cell Ther; 2022 Nov; 28(11):775.e1-775.e9. PubMed ID: 35921987
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S
Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459
[TBL] [Abstract][Full Text] [Related]
10. Total body irradiation and cyclophosphamide plus antithymocyte globulin regimen is well tolerated and promotes stable engraftment as a preparative regimen before T cell-replete haploidentical transplantation for acute leukemia.
Fu H; Xu L; Liu D; Liu K; Zhang X; Chen H; Chen Y; Han W; Wang Y; Wang J; Wang F; Huang X
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1176-82. PubMed ID: 24747336
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
12. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies.
Konuma T; Kato S; Ishii H; Oiwa-Monna M; Asano S; Tojo A; Takahashi S
Leuk Res; 2015 Jun; 39(6):625-31. PubMed ID: 25888304
[TBL] [Abstract][Full Text] [Related]
14. Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.
Tomonari A; Takahashi S; Ooi J; Nakaoka T; Takasugi K; Uchiyama M; Tsukada N; Konuma T; Iseki T; Tojo A; Asano S
Eur J Haematol; 2006 Jul; 77(1):46-50. PubMed ID: 16573743
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
17. Single-unit cord blood transplantation after granulocyte colony-stimulating factor-combined myeloablative conditioning for myeloid malignancies not in remission.
Konuma T; Kato S; Ooi J; Oiwa-Monna M; Ebihara Y; Mochizuki S; Yuji K; Ohno N; Kawamata T; Jo N; Yokoyama K; Uchimaru K; Asano S; Tojo A; Takahashi S
Biol Blood Marrow Transplant; 2014 Mar; 20(3):396-401. PubMed ID: 24333750
[TBL] [Abstract][Full Text] [Related]
18. Effect of Conditioning Regimens and Graft-versus-Host Disease Prophylaxis on the Outcomes of Umbilical Cord Blood Transplantation Performed with Cyclophosphamide/Total Body Irradiation-Based Regimens.
Imahashi N; Kurita N; Konuma T; Takahashi S; Nishida T; Tanaka M; Nakamae H; Kawakita T; Ota S; Doki N; Onishi Y; Sawa M; Ozeki K; Hiramoto N; Onizuka M; Ishimaru F; Ichinohe T; Atsuta Y; Kanda J
Transplant Cell Ther; 2024 Mar; 30(3):318.e1-318.e11. PubMed ID: 38081416
[TBL] [Abstract][Full Text] [Related]
19. Reduced-Toxicity Myeloablative Conditioning Consisting of Fludarabine/Busulfan/Low-Dose Total Body Irradiation/Granulocyte Colony-Stimulating Factor-Combined Cytarabine in Single Cord Blood Transplantation for Elderly Patients with Nonremission Myeloid Malignancies.
Konuma T; Kato S; Isobe M; Mizusawa M; Oiwa-Monna M; Takahashi S; Tojo A
Biol Blood Marrow Transplant; 2019 Apr; 25(4):764-770. PubMed ID: 30529460
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
